Robert E. Hoffman - Feb 15, 2022 Form 4 Insider Report for Kintara Therapeutics, Inc. (KTRA)

Signature
/s/ Anthony Scott Praill, attorney-in-fact for Robert E. Hoffman
Stock symbol
KTRA
Transactions as of
Feb 15, 2022
Transactions value $
$25,795
Form type
4
Date filed
2/17/2022, 03:00 PM
Previous filing
Nov 10, 2021
Next filing
Aug 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KTRA Common Stock Purchase $25.8K +55K $0.47* 55K Feb 15, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.4625 to $0.4697 per share, inclusive. The reporting person undertakes to provide to Kintara Therapeutics, Inc., any security holder of Kintara Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.